China Pharma Holdings (CPHI) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026)
China Pharma Holdings (CPHI) Property, Plant & Equipment (Net) Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.87 Bn | 42.91 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.00 Bn | 39.35 Bn | 2.15 Bn | -18.34% |
| 3 | Zoetis | 31.59 Bn | 29.92 Bn | 1.05 Bn | 6.19% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -0.59% |
| 5 | United Therapeutics | 22.15 Bn | 19.49 Bn | 683.80 Mn | 41.67% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -7.68% |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn | -1.31% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.98% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 3.94% |
| 10 | China Pharma Holdings | 41.94 Mn | 41.64 Mn | 83,566.00 | -8.78% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.90% |
| Dec 31, 2025 | -10.06% |
| Sep 30, 2025 | -15.14% |
| Jun 30, 2025 | -20.48% |
| Mar 31, 2025 | -25.94% |
| Dec 31, 2024 | -31.22% |
| Sep 30, 2024 | -31.70% |
| Jun 30, 2024 | -30.25% |
| Mar 31, 2024 | -31.59% |
| Dec 31, 2023 | -28.80% |
| Sep 30, 2023 | -25.54% |
| Jun 30, 2023 | -27.19% |
| Mar 31, 2023 | -25.35% |
| Dec 31, 2022 | -24.90% |
| Sep 30, 2022 | -24.07% |
| Jun 30, 2022 | -20.15% |
| Mar 31, 2022 | -14.46% |
| Dec 31, 2021 | -14.67% |
| Sep 30, 2021 | -13.24% |
| Jun 30, 2021 | -8.22% |